R&D trends: Biotech assets & discovery platforms
Inpart’s latest report provides access to the most promising biotech assets and discovery platforms, shedding light on the latest trends in biotech R&D.
Aurore Michelin
Articles by Aurore Michelin
Partnering 2030: FME Industries Report
Download Inpart’s new report to discover key challenges in the Food, Material, and Electromechanical (FME) industries, the best channels for sourcing new partners, and a ranking of the top companies in industry-academia partnerships.
Partnering 2030: Biopharma Report
Download Inpart’s latest report to hear from biotechs and out-licensors, following this year’s Partnering 2030 survey. The report includes real-world partnering experiences, challenges, and insights into working with top pharmaceutical firms.
Antibody Therapy R&D trends and breakthrough innovations
Check out a new report exploring R&D trends and breakthrough innovations leveraging antibodies to create potentially game-changing therapies, published by our parent company Inpart.
Podcast 16 Aug 2024
Challenging the European biotech funding status quo
Explore the latest trends in biotech investments and funding strategies in Europe with insights from 4BIO Capital’s Dima Kuzmin.
Podcast 9 Aug 2024
Rebroadcast: Epigenetic editing – the power of CRISPR without cutting DNA
This week, we discuss epigenetic editing, why it’s reversible, treating FSHD and other conditions, with Epic Bio founder, Dr Stanley Qi.
ADVERTISEMENT
ADVERTISEMENT
Podcast 2 Aug 2024
Rebroadcast: How does AI assist drug discovery?
Listen to our podcast to discover how AI is revolutionizing drug discovery by tackling “undruggable” targets like KRAS.
Podcast 24 May 2024
How biotech is tackling myasthenia gravis
To talk about the disease, how it is being treated, and what is in the pipeline for future treatments, we had a conversation with Dana Vigier, head of Central Eastern and Northern Europe at Alexion.
Inside Labiotech 20 May 2024
Participate in the 2024 Labiotech Reader Survey for a chance to win a €250 or $250 Amazon gift card!
We would like to learn more about you. Participate in the 2024 Labiotech Reader Survey for a chance to win a €250 or $250 Amazon gift card!
Reports 16 May 2023
Outsourcing in life science R&D today
Learn how online platforms facilitate outsourcing in life science R&D Dive into our report and… More about this report: Over the last two decades, outsourcing has become an integral part of life science R&D. Today, life science companies routinely outsource significant portions of their R&D activities to external suppliers – including complex, specialized services that […]
Reports 14 Feb 2023
New frontiers in vaccinology
Learn about the latest advances in vaccine technology Dive into our report and… More about this report: The rapid approval and deployment of mRNA vaccines in response to the COVID-19 pandemic catapulted nucleic acid vaccines to the world stage, with soaring scientific and public recognition of mRNA vaccines and mRNA as a promising therapeutic. In […]
Reports 15 Feb 2023
Cell Therapy Industry Report 2022
Learn about the global cell therapy industry in 2022 Dive into our report and… More about this report: By 2028, the value of the global cell therapy market is projected to surpass $45B, up from less than $20B in 2020. Some industry insiders even anticipate that cell and gene therapies will overtake conventional drug therapies […]
ADVERTISEMENT
